Single-dose modified bloodless del Nido cardioplegia for minimally invasive cardiac surgery.

ABSTRACT:

Background

Recent studies demonstrated satisfactory results of del Nido cardioplegia in minimally invasive cardiac surgery (MICS). We aimed to evaluate the efficacy of our modified "bloodless" del Nido cardioplegia in MICS compared to the histidine-tryptophan-ketoglutarate (HTK) solution.

Methods

We retrospectively reviewed 471 patients who underwent minimally invasive cardiac surgery (MICS) in our institution between January 2015 and September 2022. Patients were divided into HTK (n = 96) and bloodless del Nido (n = 375) groups. Using propensity score matching, we matched 72 patients with bloodless del Nido to 72 patients with HTK, based on demographic and operative information.

Results

There were no significant differences in the baseline characteristi

SUBMITTER: Lee H 

PROVIDER: S-EPMC11893588 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature